Arrakis Therapeutics

About:

Arrakis Therapeutics is a biopharmaceutical developing drugs for neurological disorders and other diseases.

Website: http://arrakistx.com/

Twitter/X: arrakistx

Top Investors: Pfizer, Alexandria Venture Investments, Google Ventures, WuXi AppTec, OUP (Osage University Partners)

Description:

Arrakis Therapeutics is a developer of a drug discovery platform intended to target RNA. The company's platform integrates leading-edge RNA bioinformatic and structural tools to produce a pipeline of rSMs to treat a range of disease including neurology, oncology and rare genetic diseases, enabling physicians to offer enhanced care.

Total Funding Amount:

$113M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Waltham, Massachusetts, United States

Founded Date:

2015-01-01

Contact Email:

info(AT)arrakistx.com

Founders:

Jennifer Petter, Russell C. Petter

Number of Employees:

101-250

Last Funding Date:

2019-04-18

IPO Status:

Private

Industries:

© 2025 bioDAO.ai